Current Topics in Medicinal Chemistry


Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 16 Issue: 19, August 2016

Editorial (Thematic Issue: Drug Reprofiling: An Alternative Path to Drug Discovery) free to download

Volume:16   Issue: 19
Pp: 2067-2068
C. S. Ramaa
DOI: 10.2174/156802661619160530204415
Published on: 30 May, 2016

Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?

Volume:16   Issue: 19
Pp: 2069-2077
Niteshkumar U. Sahu and Prashant S. Kharkar
DOI: 10.2174/1568026616666160216153249
Published on: 16 February, 2016

The Repurposing of Old Drugs or Unsuccessful Lead Compounds by in Silico Approaches: New Advances and Perspectives

Volume:16   Issue: 19
Pp: 2088-2106
Annamaria Martorana, Ugo Perricone and Antonino Lauria
DOI: 10.2174/1568026616666160216153457
Published on: 16 February, 2016

Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery

Volume:16   Issue: 19
Pp: 2107-2114
Haijun Chen, Jianlei Wu, Yu Gao, Haiying Chen and Jia Zhou
DOI: 10.2174/1568026616666160216155556
Published on: 16 February, 2016

Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?

Volume:16   Issue: 19
Pp: 2115-2124
Sabine Mazerbourg, Sandra Kuntz, Isabelle Grillier-Vuissoz, Audrey Berthe, Marine Geoffroy, Stéphane Flament, Andrea Bordessa and Michel Boisbrun
DOI: 10.2174/1568026616666160216153036
Published on: 16 February, 2016

Repositioning of DHFR Inhibitors

Volume:16   Issue: 19
Pp: 2125-2143
Arundhati Chandrashekhar Lele, Deepak Amarnath Mishra, Tengku Karmila Kamil, Sanjib Bhakta and Mariam Sohel Degani
DOI: 10.2174/1568026616666160216152540
Published on: 16 February, 2016

Revisiting Non-Cancer Drugs for Cancer Therapy

Volume:16   Issue: 19
Pp: 2144-2155
Eun Ju Yang, Changjie Wu, Yifan Liu, Junfang Lv and Joong Sup Shim
DOI: 10.2174/1568026616666160216154441
Published on: 16 February, 2016

An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs

Volume:16   Issue: 19
Pp: 2156-2168
Deepak Bhattarai, Sarbijt Singh, Yerin Jang, Seung Hyeon Han, Kyeong Lee and Yongseok Choi
DOI: 10.2174/1568026616666160216153618
Published on: 16 February, 2016

Repurposing Drugs for Cancer Prevention

Volume:16   Issue: 19
Pp: 2169-2178
Daniel K. Lee and Eva Szabo
DOI: 10.2174/1568026616666160216154946
Published on: 16 February, 2016

Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment

Volume:16   Issue: 19
Pp: 2179-2188
Yi C. Zheng, Bin Yu, Guo Z. Jiang, Xue J. Feng, Peng X. He, Xiao Y. Chu, Wen Zhao and Hong M. Liu
DOI: 10.2174/1568026616666160216154042
Published on: 16 February, 2016

Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario

Volume:16   Issue: 19
Pp: 2189-2200
Parmeshwar B. Katare and Sanjay K. Banerjee
DOI: 10.2174/1568026616666160216152138
Published on: 16 February, 2016

Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option

Volume:16   Issue: 19
Pp: 2201-2222
María Laura Sbaraglini, María Cristina Vanrell, Carolina Leticia Bellera, Gustavo Benaim, Carolina Carrillo, Alan Talevi and Patricia Silvia Romano
DOI: 10.2174/1568026616666160216154309
Published on: 16 February, 2016

Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug

Volume:16   Issue: 19
Pp: 2223-2230
Malgorzata Tomczynska, Michal Bijak and Joanna Saluk
DOI: 10.2174/1568026616666160216152324
Published on: 16 February, 2016